Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Barkholt, L.; Bregni, M.; Remberger, M.; Blaise, D.; Peccatori, J.; Massenkeil, G.; Pedrazzoli, P.; Zambelli, A.; Bay, J.; Francois, S.; Martino, R.; Bengala, C.; Brune, M.; Lenhoff, S.; Porcellini, A.; Falda, M.; Siena, S.; Demirer, TANER; Niederwieser, D.; Ringden, O.

doi:10.1093/annonc/mdl086

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Copy For Citation

Barkholt L., Bregni M., Remberger M., Blaise D., Peccatori J., Massenkeil G., ...More

ANNALS OF ONCOLOGY, vol.17, no.7, pp.1134-1140, 2006 (SCI-Expanded)

Publication Type: Article / Article
Volume: 17 Issue: 7
Publication Date: 2006
Doi Number: 10.1093/annonc/mdl086
Journal Name: ANNALS OF ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1134-1140
Keywords: allogeneic stem cell transplantation, antitumour effect, reduced intensity conditioning, renal cell carcinoma, GRAFT-VERSUS-LEUKEMIA, BONE-MARROW-TRANSPLANTATION, ENDOTHELIAL GROWTH-FACTOR, STATISTICAL-METHODS, HOST-DISEASE, CANCER, CHEMOTHERAPY, RECIPIENTS, THERAPY, TUMOR
Ankara University Affiliated: Yes

Abstract

Background: An allogeneic antitumour effect has been reported for various cancers. We evaluated the experience of allogeneic haematopoietic stem cell transplantation (HSCT) for renal cell carcinoma (RCC) in 124 patients from 21 European centres.